EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 3.69% over 3 years and 10.87% over 5 years. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
VRTX EBITDA CAGR Chart
Vertex Pharmaceuticals Incorporated (VRTX)
tgmcharts.com
VRTX Quarterly EBITDA Growth (YoY)
EBITDA growth vs the same quarter one year earlier, last 40 quarters.
tgmcharts.com
EBITDA
VRTX Quarterly EBITDA
$1.30B
Reported quarterly EBITDA; no daily interpolation.
